Proapoptotic effects of tau cleavage product generated by caspase-3.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Neurobiology of Disease

• Publication date

  2001-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1006/NBDI.2000.0335PMID 11162250
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β

  2000cited by this paper
• Pro‐apoptotic effects of tau mutations in chromosome 17 frontotemporal dementia and parkinsonism

  2000cited by this paper
• Involvement of Caspases in Proteolytic Cleavage of Alzheimer’s Amyloid-β Precursor Protein and Amyloidogenic Aβ Peptide Formation

  1999cited by this paper
• Neuronal overexpression of APPL, the Drosophila homologue of the amyloid precursor protein (APP), disrupts axonal transport.

  1999cited by this paper
• Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and amyloidogenic A beta peptide formation.

  1999cited by this paper
• Modulating apoptosis: current applications and prospects for future drug development.

  1999cited by this paper
• Apoptosis and autoimmune disease

  1999cited by this paper
• Tumor radiosensitivity and apoptosis.

  1999cited by this paper
• Caspases as treatment targets in stroke and neurodegenerative diseases

  1999cited by this paper
• Apoptosis in neurodegenerative diseases: the role of mitochondria.

  1999cited by this paper
• In situ immunodetection of neuronal caspase-3 activation in Alzheimer disease.

  1999cited by this paper
• Activation of Neuronal Caspase-3 by Intracellular Accumulation of Wild-Type Alzheimer Amyloid Precursor Protein

  1999cited by this paper
• Differential requirement for caspase 9 in apoptotic pathways in vivo.

  1998cited by this paper
• τ is phosphorylated by GSK‐3 at several sites found in Alzheimer disease and its biological activity markedly inhibited only after it is prephosphorylated by A‐kinase

  1998cited by this paper
• Growth hormone promotion of tubulin polymerization stabilizes the microtubule network and protects against colchicine-induced apoptosis.

  1998cited by this paper
• Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17

  1998cited by this paper
• Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9.

  1998cited by this paper
• The Neuropathology of a Chromosome 17-Linked Autosomal Dominant Parkinsonism and Dementia (“Pallido-Ponto-Nigral Degeneration”)

  1998cited by this paper
• Alteration of proteins regulating apoptosis, Bcl-2, Bcl-x, Bax, Bak, Bad, ICH-1 and CPP32, in Alzheimer's disease.

  1998cited by this paper
• Caspases: enemies within.

  1998cited by this paper
• Tau Cleavage and Dephosphorylation in Cerebellar Granule Neurons Undergoing Apoptosis

  1998cited by this paper
• Growth Hormone Promotion of Tubulin Polymerization Stabilizes the Microtubule Network and Protects Against Colchicine-Induced Apoptosis* * Supported by monies from the National Science and Technology Board of Singapore (to P.E.L.).

  1998cited by this paper
• 3-(Iodoacetamido)-benzoylurea: a novel cancericidal tubulin ligand that inhibits microtubule polymerization, phosphorylates bcl-2, and induces apoptosis in tumor cells.

  1998cited by this paper
• Increased interleukin-1beta converting enzyme expression and activity in Alzheimer disease.

  1998cited by this paper
• A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD

  1998cited by this paper
• Protein anatomy: C-tail region of human tau protein as a crucial structural element in Alzheimer's paired helical filament formation in vitro.

  1998cited by this paper
• Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis.

  1997cited by this paper
• Raf-1/bcl-2 phosphorylation: a step from microtubule damage to cell death.

  1997cited by this paper
• Carboxyl-terminal fragments of beta-amyloid precursor protein bind to microtubules and the associated protein tau.

  1997cited by this paper
• DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis.

  1997cited by this paper
• Alzheimer’s Presenilin Mutation Sensitizes Neural Cells to Apoptosis Induced by Trophic Factor Withdrawal and Amyloid β-Peptide: Involvement of Calcium and Oxyradicals

  1997cited by this paper
• Attenuation of oxidative neuronal necrosis by a dopamine D1 agonist in mouse cortical cell cultures.

  1997cited by this paper
• Stress‐Activated Protein Kinase/c‐Jun N‐Terminal Kinase Phosphorylates τ Protein

  1997cited by this paper
• Alternative cleavage of Alzheimer-associated presenilins during apoptosis by a caspase-3 family protease.

  1997cited by this paper
• Familial multiple system tauopathy with presenile dementia: a disease with abundant neuronal and glial tau filaments.

  1997cited by this paper
• Phosphorylation of microtubule‐associated protein tau by stress‐activated protein kinases

  1997cited by this paper
• Reactivating kinase/p38 phosphorylates tau protein in vitro.

  1997cited by this paper
• Reactivating Kinase/p38 Phosphorylates τ Protein In Vitro

  1997cited by this paper
• Participation of Presenilin 2 in Apoptosis: Enhanced Basal Activity Conferred by an Alzheimer Mutation

  1996cited by this paper
• Human ICE/CED-3 protease nomenclature.

  1996cited by this paper
• Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice

  1996cited by this paper
• DNA-dependent Protein Kinase Is a Target for a CPP32-like Apoptotic Protease*

  1996cited by this paper
• Suppression of Interleukin-1-converting Enzyme-mediated Cell Death by Insulin-like Growth Factor (*)

  1996cited by this paper
• Specific cleavage of the retinoblastoma protein by an ICE‐like protease in apoptosis.

  1996cited by this paper
• Peptide inhibitors of the ICE protease family arrest programmed cell death of motoneurons in vivo and in vitro.

  1995cited by this paper
• Phosphorylation of τ In Situ: Inhibition of Calcium‐Dependent Proteolysis

  1995cited by this paper
• Involvement of an ICE-like protease in Fas-mediated apoptosis

  1995cited by this paper
• Analysis of phosphorylation of tau with antibodies specific for phosphorylation sites.

  1995cited by this paper
• Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis

  1995cited by this paper
• Microtubule organization and dynamics dependent on microtubule-associated proteins.

  1994cited by this paper
• Truncated tau protein as a new marker for Alzheimer's disease.

  1994cited by this paper
• Monoclonal antibody PHF‐1 recognizes tau protein phosphorylated at serine residues 396 and 404

  1994cited by this paper
• Prevention of vertebrate neuronal death by the crmA gene.

  1994cited by this paper
• Beta-amyloid protein precursor and tau mRNA levels versus beta-amyloid plaque and neurofibrillary tangles in the aged human brain.

  1993cited by this paper
• Functional organization of microtubule-associated protein tau. Identification of regions which affect microtubule growth, nucleation, and bundle formation in vitro.

  1993cited by this paper
• Molecular characterization of the minimal protease resistant tau unit of the Alzheimer's disease paired helical filament.

  1993cited by this paper
• The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme.

  1993cited by this paper
• β‐Amyloid Protein Precursor and τ mRNA Levels Versus β‐Amyloid Plaque and Neurofibrillary Tangles in the Aged Human Brain

  1993cited by this paper
• The expression of amyloid beta protein precursor protects nerve cells from beta-amyloid and glutamate toxicity and alters their interaction with the extracellular matrix.

  1993cited by this paper
• Tau Protein and the Neurofibrillary Pathology of Alzheimer's Disease

  1993cited by this paper
• The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme

  1993cited by this paper
• Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding.

  1993cited by this paper
• Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production

  1992cited by this paper
• Role of tau in the polymerization of peptides from beta-amyloid precursor protein.

  1992cited by this paper
• Role of tau in the polymerization of peptides from β-amyloid precursor protein

  1992cited by this paper
• A novel heterodimeric cysteine protease is required for interleukin-1βprocessing in monocytes

  1992cited by this paper
• Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production.

  1992cited by this paper
• Phosphorylation by cAMP-dependent protein kinase inhibits the degradation of tau by calpain.

  1992cited by this paper
• The microtubule binding domain of tau protein.

  1989cited by this paper
• The carboxyl third of tau is tightly bound to paired helical filaments.

  1988cited by this paper

• Telomere-driven senescence accelerates tau pathology, neuroinflammation and neurodegeneration in a tauopathy mouse model

  2025cites this paper
• Sulforaphane prevents cognitive decline and mitochondrial failure induced by hippocampal expression of caspase-3 cleaved tau.

  2025cites this paper
• PCB 37 (3,4, 4’-trichlorobiphenyl) increased apoptosis and modulated neuronal morphogenesis in primary rat cortical neuron-glia cocultures in a concentration-, sex-, age-, and CREB-dependent manner

  2025cites this paper
• RILP Cleavage Links an Inflammatory State to Enhanced Tau Propagation in a Cell Culture Model of Alzheimer's Disease.

  2025cites this paper
• Influence of Tau on neurotoxicity and cerebral vasculature impairment associated with Alzheimer's disease.

  2024cites this paper
• Neuronal Vulnerability of the Entorhinal Cortex to Tau Pathology in Alzheimer’s Disease

  2024cites this paper
• Delineation of the Role of G6PD in Alzheimer's Disease and Potential Enhancement through Microfluidic and Nanoparticle Approaches.

  2024cites this paper
• Preclinical efficacy of oral and nasal rivastigmine-loaded chitosan nano-particles on AlCl3-induced Alzheimer’s-like disease in rats

  2024cites this paper
• Inflammatory cytokines, oxidative stress, and tau protein impairment in cognitive functioning in patients with diabetes mellitus

  2024cites this paper
• Tau truncation in the pathogenesis of Alzheimer’s disease: a narrative review

  2023cites this paper
• Pathological Impact of Tau Proteolytical Process on Neuronal and Mitochondrial Function: a Crucial Role in Alzheimer’s Disease

  2023cites this paper
• Cyclosporine A (CsA) prevents synaptic impairment caused by truncated tau by caspase-3.

  2023cites this paper
• CRISPR screens in iPSC-derived neurons reveal principles of tau proteostasis

  2023cites this paper
• Oligomeric, phosphorylated, and truncated tau and spliceosome pathology within the entorhinal–hippocampal connectome across stages of Alzheimer's disease

  2023cites this paper
• A Pathophysiological Intersection of Diabetes and Alzheimer’s Disease

  2022cites this paper
• Glucose metabolism and AD: evidence for a potential diabetes type 3

  2022cites this paper
• Retromer deficiency in Tauopathy models enhances the truncation and toxicity of Tau

  2022cites this paper
• Caspase-cleaved tau is senescence-associated and induces a toxic gain of function by putting a brake on axonal transport

  2022cites this paper
• Alzheimer's disease is an inherent, natural part of human brain aging: an integrated perspective.

  2022cites this paper
• Naturally Occurring Antioxidant Therapy in Alzheimer’s Disease

  2022cites this paper
• Role of Aβ in Alzheimer’s-related synaptic dysfunction

  2022cites this paper
• Interaction between Aβ and Tau in the Pathogenesis of Alzheimer's Disease

  2021cites this paper
• Visualization of neurofibrillary tangle maturity in Alzheimer's disease: A clinicopathologic perspective for biomarker research

  2021cites this paper
• Contribution of the Nrf2 Pathway on Oxidative Damage and Mitochondrial Failure in Parkinson and Alzheimer’s Disease

  2021cites this paper
• Tau Protein Interaction Partners and Their Roles in Alzheimer’s Disease and Other Tauopathies

  2021cites this paper
• Caspase-6-cleaved Tau fails to induce Tau hyperphosphorylation and aggregation, neurodegeneration, glial inflammation, and cognitive deficits

  2021cites this paper
• Scavenging amyloid oligomers from neurons with silica nanobowls: Implications for amyloid diseases

  2021cites this paper
• Tau Post-translational Modifications: Dynamic Transformers of Tau Function, Degradation, and Aggregation

  2021cites this paper
• Possible Mechanisms of Tau Spread and Toxicity in Alzheimer’s Disease

  2021influential citation
• Title: Oxidative Stress in Alzheimer’s Disease: A Review on Emergent Natural Polyphenolic Therapeutics

  2021cites this paper
• Oxidative stress in alzheimer's disease: A review on emergent natural polyphenolic therapeutics.

  2020cites this paper
• Small molecule therapeutics for tauopathy in Alzheimer's disease: Walking on the path of most resistance.

  2020cites this paper
• Tau Filament Self-Assembly and Structure: Tau as a Therapeutic Target

  2020cites this paper
• N-terminal tau truncation in the pathogenesis of Alzheimer's disease (AD): Developing a novel diagnostic and therapeutic approach.

  2020cites this paper
• Tau immunophenotypes in chronic traumatic encephalopathy recapitulate those of ageing and Alzheimer's disease.

  2020cites this paper
• An update on the association between traumatic brain injury and Alzheimer's disease : focus on tau pathology and synaptic dysfunction.

  2020cites this paper
• LncRNA miR503HG Regulates the Drug Resistance of Recurrent Cervical Squamous Cell Carcinoma Cells by Regulating miR-155/Caspase-3

  2020cites this paper
• Analysis of the Relationship Between Metalloprotease-9 and Tau Protein in Alzheimer’s Disease

  2020cites this paper
• Exoenzyme Y induces extracellular active caspase-7 accumulation independent from apoptosis: Modulation of transmissible cytotoxicity.

  2020cites this paper
• Small molecule modulation of the p75 neurotrophin receptor inhibits multiple amyloid beta-induced tau pathologies

  2020cites this paper
• Tau pathology in the medial temporal lobe of athletes with chronic traumatic encephalopathy: a chronic effects of neurotrauma consortium study

  2019cites this paper
• Altered Cytoskeletal Composition and Delayed Neurite Elongation in tau45-230-Expressing Hippocampal Neurons.

  2019cites this paper
• Molecular mechanisms of cellular dysfunction caused by a tauopathy-associated fragment

  2019cites this paper
• Rho-kinase ROCK inhibitors reduce oligomeric tau protein.

  2019cites this paper
• CNS Injury: Posttranslational Modification of the Tau Protein as a Biomarker

  2019cites this paper
• Apelin, a promising target for Alzheimer disease prevention and treatment.

  2018cites this paper
• Genetically enhancing the expression of chemokine domain of CX3CL1 fails to prevent tau pathology in mouse models of tauopathy

  2018cites this paper
• Tau Abnormalities and the Potential Therapy in Alzheimer’s Disease

  2018cites this paper
• Pseudo‐phosphorylation at AT8 epitopes regulates the tau truncation at aspartate 421

  2018cites this paper
• Homocysteine Increases Tau Phosphorylation, Truncation and Oligomerization

  2018cites this paper
• Tau Biology, Tauopathy, Traumatic Brain Injury, and Diagnostic Challenges

  2018cites this paper
• Hyperphosphorylation of Tau Associates With Changes in Its Function Beyond Microtubule Stability

  2018cites this paper
• New Insight into Alzheimer's Disease via Caspase 3-cleaved Tau: Pathogenic Role in Tau Oligomer Formation and Memory Deficits

  2017cites this paper
• Characterization of TauC3 antibody and demonstration of its potential to block tau propagation

  2017cites this paper
• Pimozide reduces toxic forms of tau in TauC3 mice via 5′ adenosine monophosphate‐activated protein kinase‐mediated autophagy

  2017cites this paper
• Abolishing Tau cleavage by caspases at Aspartate421 causes memory/synaptic plasticity deficits and pre-pathological Tau alterations

  2017cites this paper
• Investigating the contribution of astrocytes and neuroinflammation to pathological tau changes in Alzheimer's disease

  2017cites this paper
• Novel Cell Model for Tauopathy Induced by a Cell-Permeable Tau-Related Peptide.

  2017cites this paper
• Chronic traumatic encephalopathy‐integration of canonical traumatic brain injury secondary injury mechanisms with tau pathology

  2017cites this paper
• Methods related to studying tau fragmentation.

  2017cites this paper
• JNK signaling pathway regulates sorbitol-induced Tau proteolysis and apoptosis in SH-SY5Y cells by targeting caspase-3.

  2017cites this paper
• association with the cytoskeleton and membrane-bound organelles : functional implications in neurodegeneration

  2017cites this paper
• Caspase-3-Dependent Proteolytic Cleavage of Tau Causes Neurofibrillary Tangles and Results in Cognitive Impairment During Normal Aging

  2016cites this paper
• Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

  2016cites this paper
• Herpes Simplex Virus Type 1 Neuronal Infection Elicits Cellular and Molecular Mechanisms of Neuroinflammation and Neurodegeneration in in vitro and in vivo Mice Models.

  2016cites this paper
• Hyperosmotic Stress Induces Tau Proteolysis by Caspase‐3 Activation in SH‐SY5Y Cells

  2016influential citation
• Caspase-cleaved Tau-D(421) is colocalized with the immunophilin FKBP52 in the autophagy-endolysosomal system of Alzheimer's disease neurons.

  2016cites this paper
• Tauopathy induced by low level expression of a human brain-derived tau fragment in mice is rescued by phenylbutyrate

  2016cites this paper
• An antioxidant specifically targeting mitochondria delays progression of Alzheimer's disease-like pathology

  2016cites this paper
• Changes in the transcriptome of the prefrontal cortex of OXYS rats as signs of the development of Alzheimer’s disease

  2016cites this paper
• [Gly14]-Humanin Protects Against Amyloid β Peptide-Induced Impairment of Spatial Learning and Memory in Rats

  2016cites this paper
• The Metamorphic Nature of the Tau Protein: Dynamic Flexibility Comes at a Cost

  2016cites this paper
• Investigating the mechanisms underlying Alzheimer's disease using a novel organotypic brain slice culture model

  2016cites this paper
• Multiple signaling factors and drugs alleviate neuronal death induced by expression of human and zebrafish tau proteins in vivo

  2016cites this paper
• Characterization of Early Pathological Tau Conformations and Phosphorylation in Chronic Traumatic Encephalopathy

  2016cites this paper
• Presence of insoluble Tau following rotenone exposure ameliorates basic pathways associated with neurodegeneration

  2016cites this paper
• Commentary on Ubiquitin is Associated with Early Truncation of Tau Protein at Aspartic Acid421 during the Maturation of Neurofibrillary Tangles in Alzheimer Disease

  2016cites this paper
• Caspase-cleaved tau exhibits rapid memory impairment associated with tau oligomers in a transgenic mouse model.

  2016cites this paper
• Tau and tauopathies.

  2016cites this paper
• Signaling pathways and posttranslational modifications of tau in Alzheimer's disease: the humanization of yeast cells.

  2016cites this paper
• BDNF trafficking and signaling impairment during early neurodegeneration is prevented by moderate physical activity

  2016cites this paper
• Tau Hyperphosphorylation and Oxidative Stress, a Critical Vicious Circle in Neurodegenerative Tauopathies?

  2015cites this paper
• In vitro and in vivo characterization of the E3 ubiquitin ligase RNF157 in the brain

  2015cites this paper
• Can agrin CSF concentration be used as an early biomarker for Alzheimer ’ s disease ?

  2015cites this paper
• Protein Misfolding, Neurodegeneration and Tau

  2015cites this paper
• Microtubule‐associated protein tau promotes neuronal class II β‐tubulin microtubule formation and axon elongation in embryonic Xenopus laevis

  2015cites this paper
• De la cellule au primate, propagation physiopathologique de la protéine Tau

  2015cites this paper
• Neuronal degeneration, synaptic defects, and behavioral abnormalities in tau₄₅₋₂₃₀ transgenic mice.

  2014cites this paper
• Thesis committee members

  2014cites this paper
• Late-Onset Alzheimer's Disease, Heating up and Foxed by Several Proteins: Pathomolecular Effects of the Aging Process

  2014cites this paper
• The expression of apoptosis inducing factor (AIF) is associated with aging-related cell death in the cortex but not in the hippocampus in the TgCRND8 mouse model of Alzheimer’s disease

  2014cites this paper
• The molecular intersection between axon-specific pruning and neuronal apoptosis

  2014cites this paper
• Post-Translational Modifications in Alzheimer's Disease and the Potential for New Biomarkers

  2014cites this paper
• Tau Clearance Mechanisms and Their Possible Role in the Pathogenesis of Alzheimer Disease

  2013cites this paper
• Characterization of Thorn‐Shaped Astrocytes in White Matter of Temporal Lobe in Alzheimer's Disease Brains

  2013cites this paper
• DEPARTMENT OF SURGERY PROTOCOL INDEX

  2013influential citation
• Proteolytic cleavage of polymeric tau protein by caspase-3: implications for Alzheimer disease.

  2013cites this paper
• Mouse models for the investigation of MAPT and its role in neurodegenerative disease

  2013cites this paper
• Prostate-derived Sterile 20-like Kinases (PSKs/TAOKs) Phosphorylate Tau Protein and Are Activated in Tangle-bearing Neurons in Alzheimer Disease*

  2013cites this paper
• A Rapid Gene Delivery–Based Mouse Model for Early-Stage Alzheimer Disease–Type Tauopathy

  2013cites this paper